United Therapeutics Corp.

United Therapeutics Corporation develops pharmaceuticals to treat vascular disease, including pulmonary hypertension and peripheral vascular disease, as well as selected other chronic conditions. United Therapeutic Corporation's common stock began trading on the Nasdaq Stock Market's Nasdaq National Market on June 17, 1999 under

Activity:

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: Europe , North America , Asia , Africa , South America , Near/Middle East , Far East

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: